Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Other-Income-Expense-Net" stands at -1.58 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2023.
Merck & Company Inc's third quarter result of -0.811 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -46.65 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of -0.811 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -865.09 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of -1.58 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -139.15 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.37 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.37 Billion United States Dollars.
The 3 year change is 0.128 Billion United States Dollars.
The 5 year change is -1.97 Billion United States Dollars.
The 10 year change is -10.85 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |